Welcome to our dedicated page for NORTECH SYSTEMS SEC filings (Ticker: NSYS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on NORTECH SYSTEMS's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into NORTECH SYSTEMS's regulatory disclosures and financial reporting.
Nortech Systems Incorporated (NSYS) reported higher sales and a return to profitability for the six months ended June 30, 2026. Net sales rose to $33.5 million for the quarter and $63.9 million year-to-date, up 9.3% and 10.9% from the prior-year periods, driven mainly by strong growth in Medical Device and Medical Imaging markets. For the six-month period, net income improved to $0.3 million from a loss of $1.0 million a year earlier, as gross margin expanded.
Gross profit increased to $10.4 million for the first half of 2026, with gross margin improving to 16.3% from 13.7%, reflecting higher volumes and better manufacturing cost absorption, partially offset by an unfavorable sales mix. Operating income for the first six months was $0.7 million, compared with an operating loss of $0.9 million in the prior-year period, aided by the absence of prior restructuring charges despite higher incentive compensation.
Total assets were $80.0 million and shareholders’ equity $35.5 million at June 30, 2026. The company had $7.9 million of lines of credit and current term debt, supported by a new $15.0 million Associated Bank credit facility and term loan maturing in 2029, with covenant compliance reported. Ninety-day backlog rose to $33.4 million and total backlog to $93.8 million, both higher than a year earlier, signaling continued demand, particularly in Aerospace and Defense.
Nortech Systems Incorporated reported higher revenue for the quarter ended June 30, 2026. Net sales were $33.5 million in Q2 2026, up 9.3% from $30.7 million in Q2 2025, with gross profit rising to $5.7 million and gross profit for the first half of 2026 up 31.5% year over year.
Q2 2026 net income was $316 thousand, or $0.11 per basic share, roughly flat versus $313 thousand, or $0.12 per basic share, a year earlier. For the first six months, net income improved to $282 thousand from a loss of $1.0 million in 2025, and Adjusted EBITDA increased to $1.3 million from $73 thousand. However, Q2 EBITDA and Adjusted EBITDA of $938 thousand declined 12.6% from Q2 2025.
The company highlighted a strong order pipeline, with a 90‑day backlog of $33.4 million and total backlog of $93.8 million as of June 30, 2026, up 20% from a year earlier. Cash and restricted cash totaled $1.7 million, operating cash flow for the first half was a use of $2.4 million, and total assets were $80.0 million against total liabilities of $44.6 million.
Nortech Systems Incorporated reported the results of its annual meeting of shareholders held on May 13, 2026. Shareholders voted on the election of directors to the board.
Each of the six director nominees received strong support, with votes for each candidate around 1.59–1.60 million and only a few thousand votes withheld. There were 401,530 broker non-votes recorded for each nominee, indicating some shares were not voted on the election proposal. As a result, all listed nominees were elected to continue serving on the company’s board of directors.
Nortech Systems Incorporated reported improved first quarter 2026 results. Net sales rose to $30.3 million from $26.9 million in Q1 2025, driven by growth across key end markets. Gross profit increased to $4.7 million from $3.1 million while operating expenses were essentially flat, resulting in income from operations of $47 thousand versus a prior-year loss.
The company’s net loss narrowed sharply to $34 thousand, or $0.01 per basic share, compared with a $1.3 million loss, or $0.48 per share, a year earlier. Adjusted EBITDA turned positive at $350 thousand, compared with a $1.0 million loss. The 90-day backlog reached $31.5 million and total backlog was $90.8 million as of March 31, 2026, and the company closed on $17.2 million of debt financing to support its operations and strategy.
Nortech Systems reported higher sales and sharply improved profitability for the quarter ended March 31, 2026. Net sales rose to $30,316 from $26,895, led by growth in Medical Imaging and Aerospace and Defense.
Gross profit increased to $4,702, lifting gross margin to 15.5% from 11.4%, as plant utilization improved after prior restructuring. The company posted a small net loss of $34, significantly better than the $1,316 loss a year earlier.
Operating cash outflow narrowed to $1,561, while cash and restricted cash ended at $2,208. A new $15,000 Associated Bank revolving credit facility and a $2,200 term loan, maturing in 2029, refinanced the prior revolver and support liquidity. Total backlog climbed to $90,802, up strongly year over year, with particular strength in Aerospace and Defense.
Nortech Systems Incorporated filed Amendment No. 1 to its Annual Report for the year ended December 31, 2025, solely to add conformed signatures and updated CEO/CFO certifications; no financial statements or other disclosures were changed.
The company provides engineering and manufacturing services for complex electromedical, aerospace and defense, and industrial products from facilities in the U.S., Mexico and China. In 2025, net sales were $118,365 thousand with over 50% from medical-related markets, one customer represented 32.2% of net sales, and year-end total backlog was $77,343 thousand. Non‑affiliate market value was $11.81 million at a share price of $8.93, with 2,786,134 shares outstanding as of February 28, 2026.
Nortech Systems Incorporated calls a virtual annual shareholder meeting on May 13, 2026. Shareholders of record as of March 20, 2026, when 2,786,134 common shares were outstanding, may vote online.
Investors will elect six directors, cast an advisory Say‑on‑Pay vote on named executive officer compensation, ratify Baker Tilly US, LLP as auditor for 2026, and vote on a new 2026 Equity Incentive Plan authorizing up to 250,000 shares plus any remaining shares from the 2017 plan. The company is a Nasdaq “controlled company,” with a Kunin family group holding 52.9% of voting power, yet the board currently has a majority of independent directors and fully independent audit, compensation and nominating committees.
Nortech Systems Incorporated reported improved fourth-quarter 2025 results, returning to profitability on higher margins despite lower full-year sales. For Q4 2025, net sales were $30.3 million, up from $28.6 million a year earlier, while net income reached $897 thousand, or $0.32 per basic share, compared with a loss of $1.5 million, or $(0.54) per share, in Q4 2024. Gross profit nearly doubled to $5.1 million and adjusted EBITDA improved to $1.2 million from a loss in the prior-year quarter.
For full-year 2025, net sales were $118.4 million versus $128.1 million in 2024, but the net loss narrowed to $252 thousand from $1.3 million, and adjusted EBITDA rose to $2.5 million from $2.1 million. The company reported a 90‑day backlog of $27.3 million as of December 31, 2025 and closed $17.2 million of debt financing, while emphasizing ongoing restructuring benefits, margin gains, and an AS9100:D certification at its Monterrey facility.
Nortech Systems Incorporated reported 2025 net sales of $118,365 thousand, down 7.6% from 2024, as Medical Device, Industrial, and Aerospace & Defense volumes softened while Medical Imaging grew. Despite lower revenue, gross margin improved to 15.2% from 13.1%, helped by better plant utilization and business mix.
The company generated operating income of $975 thousand but recorded a small net loss of $252 thousand. Backlog strengthened, with total orders rising 17.4% to $77,343 thousand and 90‑day backlog up 3.2%, reflecting demand and shipment timing. One customer accounted for 32.2% of 2025 net sales, underscoring customer concentration risk.
Nortech operates EMS facilities in Minnesota, Mexico, and China, serving Medical Device, Medical Imaging, Aerospace & Defense, and Industrial OEMs. It invested $1,172 thousand in research and development and ended the year with 685 full‑time employees. The company has a new asset‑based credit facility providing up to $15,000 thousand in revolving capacity plus a $2,200 thousand term loan, subject to financial covenants such as a 1.10x fixed charge coverage ratio.
Nortech Systems Incorporated entered into a new Credit and Security Agreement with Associated Bank that provides a revolving credit facility of up to $15,000,000 and a $2,200,000 term loan. This replaces the company’s prior facility that was due to mature in August 2026.
The new facility includes a $1,500,000 letter-of-credit sublimit, is secured by substantially all U.S. assets, and the revolver and term loan each mature in March 2029. Borrowings bear interest at a base rate or one- or three-month Term SOFR plus 2.00% for revolver borrowings and 2.25% for the term loan.
The agreement includes customary covenants limiting additional debt, liens, investments, asset sales, dividends, and certain transactions without lender consent. Nortech must maintain a Fixed Charge Coverage Ratio of 1.10 to 1.00 and comply with broad event-of-default provisions, including non-compliance, change of control, destruction of collateral, or a material adverse effect.